Skip to main content

Ublituximab-xiiy (Intravenous)

Generic name: ublituximab-xiiy [ ue-bli-TUX-i-mab-- xiiy ]
Drug class: CD20 monoclonal antibodies

Medically reviewed by Drugs.com. Last updated on Feb 12, 2024.

Uses for ublituximab-xiiy

Ublituximab-xiiy injection is used to treat the relapsing forms (including clinically isolated syndrome, relapsing-remitting disease, and active secondary progressive disease) of multiple sclerosis (MS). This medicine will not cure MS, but it may slow some of the disabling effects and decrease the number of relapses of the disease.

This medicine is to be given only by or under the direct supervision of your doctor.

Before using ublituximab-xiiy

In deciding to use a medicine, the risks of taking the medicine must be weighed against the good it will do. This is a decision you and your doctor will make. For this medicine, the following should be considered:

Allergies

Tell your doctor if you have ever had any unusual or allergic reaction to this medicine or any other medicines. Also tell your health care professional if you have any other types of allergies, such as to foods, dyes, preservatives, or animals. For non-prescription products, read the label or package ingredients carefully.

Pediatric

Appropriate studies have not been performed on the relationship of age to the effects of ublituximab-xiiy injection in the pediatric population. Safety and efficacy have not been established.

Geriatric

Appropriate studies performed to date have not demonstrated geriatric-specific problems that would limit the usefulness of ublituximab-xiiy injection in the elderly.

Breast Feeding

There are no adequate studies in women for determining infant risk when using this medication during breastfeeding. Weigh the potential benefits against the potential risks before taking this medication while breastfeeding.

Interactions with Medicines

Although certain medicines should not be used together at all, in other cases two different medicines may be used together even if an interaction might occur. In these cases, your doctor may want to change the dose, or other precautions may be necessary. When you are receiving this medicine, it is especially important that your healthcare professional know if you are taking any of the medicines listed below. The following interactions have been selected on the basis of their potential significance and are not necessarily all-inclusive.

Using this medicine with any of the following medicines is usually not recommended, but may be required in some cases. If both medicines are prescribed together, your doctor may change the dose or how often you use one or both of the medicines.

Interactions with Food/Tobacco/Alcohol

Certain medicines should not be used at or around the time of eating food or eating certain types of food since interactions may occur. Using alcohol or tobacco with certain medicines may also cause interactions to occur. Discuss with your healthcare professional the use of your medicine with food, alcohol, or tobacco.

Other Medical Problems

The presence of other medical problems may affect the use of this medicine. Make sure you tell your doctor if you have any other medical problems, especially:

Proper use of ublituximab-xiiy

A nurse or other trained health professional will give you this medicine in a medical facility. It is given through a needle placed into one of your veins.

You will receive the first dose of this medicine that will last for at least 4 hours. Your second dose will be given 2 weeks after your first dose for at least 1 hour. You will receive your next doses as 1 infusion every 24 weeks that will last for at least 1 hour.

This medicine should come with a Medication Guide. Read and follow the instructions carefully. Ask your doctor if you have any questions.

Your doctor may give you other medicines (eg, allergy medicine, fever medicine, steroid) 30 to 60 minutes before receiving this medicine to prevent unwanted effects (eg, infusion reactions). Your doctor may also want you to stay for at least 1 hour after the first 2 infusions to check for unwanted effects.

Missed Dose

Call your doctor or pharmacist for instructions.

Detailed Ublituximab dosage information

Precautions while using ublituximab-xiiy

It is very important that your doctor check your progress at regular visits to make sure this medicine is working properly. Blood and urine tests may be needed to check for any unwanted effects.

Receiving this medicine while you are pregnant can harm your unborn baby. If you are a woman who can get pregnant, your doctor may do tests to make sure you are not pregnant before receiving this medicine. Use an effective form of birth control to keep from getting pregnant during treatment with this medicine and for 6 months after the last dose. If you think you have become pregnant while receiving this medicine, tell your doctor right away.

This medicine may cause infusion reaction, which can be life-threatening and requires immediate medical attention. Tell your doctor right away if you start to have chest tightness, chills, cough, difficulty swallowing, dizziness, fever, headache, nausea, fast, pounding, or irregular heartbeat or pulse, lightheadedness or faintness, puffiness or swelling of the eyelids or around the eyes, face, lips, or tongue, sore throat, swelling in your face or hands, skin itching, redness, rash, or hives, trouble breathing, or unusual tiredness or weakness while you are receiving this medicine.

This medicine may increase your risk of developing infections. Avoid being near people who are sick or have infections while you are using this medicine. Wash your hands often. Also tell your doctor if you have ever had an infection that would not go away or an infection that kept coming back.

This medicine may cause hepatitis B virus reactivation. Tell your doctor right away if you have yellow skin or eyes, dark brown-colored urine, right-sided stomach pain, fever, or severe tiredness.

This medicine may increase your risk of developing infections, including a rare and serious brain infection called progressive multifocal leukoencephalopathy (PML). This is more likely to occur if you have JCV infection. Check with your doctor if you have weakness on one side of the body, clumsiness, blurred vision, changes in thinking, memory problems, confusion, or personality changes.

While you are being treated with ublituximab-xiiy, and after you stop treatment with it, do not have any immunizations (vaccinations) without your doctor's approval. Complete any required live or live-attenuated vaccines at least 4 weeks, or non-live vaccines at least 2 weeks, before starting this medicine. This medicine may lower your body's resistance and there is a chance you might get the infection the immunization is meant to prevent. In addition, other persons living in your household should not take oral polio vaccine since there is a chance they could pass the polio virus on to you. Also, avoid persons who have taken oral polio vaccine within the last several months. Do not get close to them, and do not stay in the same room with them for very long. If you cannot take these precautions, you should consider wearing a protective face mask that covers the nose and mouth.

Do not take other medicines unless they have been discussed with your doctor. This includes prescription or nonprescription (over-the-counter [OTC]) medicines and herbal or vitamin supplements.

Side Effects of ublituximab-xiiy

Along with its needed effects, a medicine may cause some unwanted effects. Although not all of these side effects may occur, if they do occur they may need medical attention.

Check with your doctor or nurse immediately if any of the following side effects occur:

More common

Incidence not known

Some side effects may occur that usually do not need medical attention. These side effects may go away during treatment as your body adjusts to the medicine. Also, your health care professional may be able to tell you about ways to prevent or reduce some of these side effects. Check with your health care professional if any of the following side effects continue or are bothersome or if you have any questions about them:

More common

Other side effects not listed may also occur in some patients. If you notice any other effects, check with your healthcare professional.

Call your doctor for medical advice about side effects. You may report side effects to the FDA at 1-800-FDA-1088.

Available Dosage Forms:

Therapeutic Class: Immune Modulator

Pharmacologic Class: Ublituximab

Ublituximab side effects (more detail)

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Medical Disclaimer